Alpha 1-antitrypsin deficiency: Difference between revisions
No edit summary |
|||
| Line 37: | Line 37: | ||
[[Alpha 1-antitrypsin deficiency primary prevention|Primary Prevention]] | [[Alpha 1-antitrypsin deficiency secondary prevention|Secondary Prevention]] | [[Alpha 1-antitrypsin deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Alpha 1-antitrypsin deficiency future or investigational therapies|Future or Investigational Therapies]] | [[Alpha 1-antitrypsin deficiency primary prevention|Primary Prevention]] | [[Alpha 1-antitrypsin deficiency secondary prevention|Secondary Prevention]] | [[Alpha 1-antitrypsin deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Alpha 1-antitrypsin deficiency future or investigational therapies|Future or Investigational Therapies]] | ||
== | ==See Also== | ||
* [[COPD]] | * [[COPD]] | ||
* [[Emphysema]] | * [[Emphysema]] | ||
Revision as of 20:11, 26 August 2012
For patient information, click here Template:DiseaseDisorder infobox
|
Alpha 1-antitrypsin deficiency Microchapters |
|
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Alpha 1-antitrypsin deficiency On the Web |
|
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency |
|
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
|
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Pathophysiology
Differentiating Alpha 1-antitrypsin deficiency from other Diseases
Epidemiology and Demographics
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical: Medical Therapy
Surgical: Surgery
Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies